Investments
1Portfolio Exits
1Latest Larry Hsu News
Larry Hsu 2.0: Generic drug trailblazer's new branded drug company targets rare tumors and more
Dec 15, 2021
"When I drive, I don't look at the rearview mirror," the AmMax Bio chairman and CEO said. "I drive forward."
Larry Hsu Investments
1 Investments
Larry Hsu has made 1 investments. Their latest investment was in Armetheon as part of their Series A on August 8, 2014.
Larry Hsu Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
8/28/2014 | Series A | Armetheon | $7M | Yes | 4 |
Date | 8/28/2014 |
|---|---|
Round | Series A |
Company | Armetheon |
Amount | $7M |
New? | Yes |
Co-Investors | |
Sources | 4 |
Larry Hsu Portfolio Exits
1 Portfolio Exit
Larry Hsu has 1 portfolio exit. Their latest portfolio exit was Armetheon on March 30, 2017.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
3/30/2017 | Merger | 1 |
Date | 3/30/2017 |
|---|---|
Exit | Merger |
Companies | |
Valuation | |
Acquirer | |
Sources | 1 |